Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis

por Salvo, Elizabeth M., Ramirez, Abril Oliva, Cueto, Jenilee, Law, Ernest H., Situ, Aaron, Cameron, Chris, Samjoo, Imtiaz A.
Publicado 2021

Population-based recurrence rates among older women with HR-positive, HER2-negative early breast cancer: Clinical risk factors, frailty status, and differences by race

por Zhou, Jifang, Cueto, Jenilee, Ko, Naomi Y., Hoskins, Kent F., Nabulsi, Nadia A., Asfaw, Alemseged A., Hubbard, Colin C., Mitra, Debanjali, Calip, Gregory S., Law, Ernest H.
Publicado 2021

Impact of time to distant recurrence on breast cancer-specific mortality in hormone receptor-positive breast cancer

por Calip, Gregory S., Nabulsi, Nadia A., Hubbard, Colin, Asfaw, Alemseged A., Lee, Inyoung, Zhou, Jifang, Cueto, Jenilee, Mitra, Debanjali, Ko, Naomi Y., Hoskins, Kent F., Law, Ernest H.
Publicado 2022

Health-related Quality of Life in Hormone Receptor-Positive Early Breast Cancer: Analyses From the Surveillance, Epidemiology, and End Results Medicare Health Outcomes Survey

por Nabulsi, Nadia A, Naing, Khatija W, Deng, Huiwen, Cueto, Jenilee, Asfaw, Alemseged A, Hubbard, Colin C, Zhou, Jifang, Lee, Inyoung, Mitra, Debanjali, Calip, Gregory S, Law, Ernest H
Publicado 2022